FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/05/2025
Back to search
Official data from USPTO
IMMAGINA BIOTECHNOLOGY THE RIBOSOME COMPANY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
07/16/2026
Trademark type
Combined
Nice classes
1, 5, 10
Filing date
09/13/2022
Registration date
07/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/09/2024
Last transaction
07/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
IT
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a circle containing a stylized trident with three partial circles above each tip, all above the stylized wording "IMMAGINA BIOTECHNOLOGY THE RIBOSOME COMPANY". A small shaded dot frames either side of "BIOTECHNOLOGY".
Holders and representatives
Holders
Immagina Biotechnology S.r.l.
Representatives
ALI R. LATIFI Tucker & Latifi, LLP
Technical classification
Nice Classes
Class 1Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical substances for analyses in laboratoriesother than for medical or veterinary purposeschemical for use in industry and natural elementsradiative elements for scientific purposes; nucleic acid sequencing programs other than for medical usenucleic acid sequences and chemical reagents for other than medical or veterinary purposes; chemical compositions and materials for use in sciencechemicals for use in science; chemical reagent mixtures in kit form comprised of chemical reagents other than for medical or veterinary use; chemical reagents other than for medical or veterinary purposes for use in the field of scientific research; chemicals for use in performing nucleic acid polymerase chain reactions other than medical and veterinary purposes; chemical diagnostic reagents for industrial purposescellular culture environmentscellular regulation agentsamino acidsdna fragmentsrna fragmentsdna probesrna probesmaterial for genetic cloningtagged antibodies for laboratory use; protein in raw material form for scientific and medical research; photosensitive chemicals being chemical preparations for use in photography; activators being chemicals for use in industry and science
Class 5
Stem cells for medical purposes; chemico-pharmaceutical preparations for treating cancer; chemical preparations for medical purposesfor treating cancer; chemical preparations for pharmaceutical purposes for the treatment of renal disease; diagnostic preparations for medical purposesfor diagnosing cardiovascular conditions; pharmaceutical preparations for treating cancer; clinical diagnostic reagents being diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; swabs for medical purposes; biological reagents for medical use; biotechnological preparations for medical use for treating cancer; antibodiescolostral antibodies for medical purposes; regulatory proteins for medical useprotein arrays for medical diagnosis purposes; enzymes for medical and veterinary purposes
Class 10
Screening kitapparatus for DNA and RNA testing for medical purposes; biomedical diagnostic apparatusmolecular diagnostic devices for medical purposes used for nucleic acid testinginfectious disease testinggenetic testing; biomedical devices in the nature of cartridgesunfilledfor medical purposesfor loading biological samples for use in molecular diagnostic devices; testing sample collection equipmentswabs for obtaining biological samples from subjects for biomedical purposes; apparatus for dna and rna testing for medical purposes; apparatus for carrying-out diagnostic tests for medical purposesapparatus for DNA and RNA testing for medical purposes; screening kits for medical purposesapparatus for DNA and RNA testing for medical purposes; probes for medical purposes; sensor apparatus for medical use in diagnosispatient monitoring sensors and alarms
Publications
History of USPTO decisions and trademark events.
42 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/18/2024
FIMP
FINAL DISPOSITION PROCESSED
12/17/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/09/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/09/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/07/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/23/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/23/2024
PUBO
PUBLISHED FOR OPPOSITION
04/23/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/03/2024
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/14/2024
ALIE
ASSIGNED TO LIE
03/14/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/05/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/05/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/27/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/09/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/09/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/09/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2024
RFNT
REFUSAL PROCESSED BY IB
08/29/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/09/2023
RFRR
REFUSAL PROCESSED BY MPU
08/09/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/04/2023
CNRT
NON-FINAL ACTION WRITTEN
07/03/2023
DOCK
ASSIGNED TO EXAMINER
06/26/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/27/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/27/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/27/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/27/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/27/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/27/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/15/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/11/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/09/2023
Continuous trademark protection
Get notified about every new filing that threatens IMMAGINA BIOTECHNOLOGY THE RIBOSOME COMPANY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.